Trial intelligence / Profile preview

Comparison of intravenous, local and oral tranexamic acid on postoperative bleeding in coronary artery bypass graft surgery

IRCT20141209020258N166Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in coronary arteriosclerosis (3 arms), sponsored by Arak University of Medical Sciences. Started Oct 2021; status: completed.

02

Drugs

tranexamic acid
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on IRCT20141209020258N166.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N166.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call